Group One Trading’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $580K | Buy |
162,000
+125,100
| +339% | +$497K | ﹤0.01% | 3209 |
|
|
2025
Q4 | $130K | Sell |
36,900
-144,600
| -80% | -$495K | ﹤0.01% | 4772 |
|
|
2025
Q3 | $592K | Buy |
181,500
+131,300
| +262% | +$414K | ﹤0.01% | 3522 |
|
|
2025
Q2 | $123K | Sell |
50,200
-300
| -0.6% | -$1.52K | ﹤0.01% | 4789 |
|
|
2025
Q1 | $337K | Buy |
50,500
+43,800
| +654% | +$433K | ﹤0.01% | 3470 |
|
|
2024
Q4 | $84.2K | Sell |
6,700
-7,800
| -54% | -$117K | ﹤0.01% | 4653 |
|
|
2024
Q3 | $268K | Sell |
14,500
-10,900
| -43% | -$223K | ﹤0.01% | 3360 |
|
|
2024
Q2 | $547K | Sell |
25,400
-73,700
| -74% | -$1.69M | ﹤0.01% | 2480 |
|
|
2024
Q1 | $2.67M | Buy |
99,100
+52,400
| +112% | +$1.49M | 0.01% | 1281 |
|
|
2023
Q4 | $1.4M | Sell |
46,700
-34,300
| -42% | -$757K | ﹤0.01% | 2153 |
|
|
2023
Q3 | $1.66M | Buy |
81,000
+57,700
| +248% | +$1.05M | 0.01% | 1797 |
|
|
2023
Q2 | $463K | Buy |
23,300
+6,000
| +35% | +$121K | ﹤0.01% | 3108 |
|
|
2023
Q1 | $296K | Buy |
17,300
+9,400
| +119% | +$184K | ﹤0.01% | 3294 |
|
|
2022
Q4 | $155K | Sell |
7,900
-9,200
| -54% | -$169K | ﹤0.01% | 4074 |
|
|
2022
Q3 | $273K | Buy |
17,100
+5,300
| +45% | +$82.7K | ﹤0.01% | 3841 |
|
|
2022
Q2 | $162K | Buy |
+11,800
| New | +$141K | ﹤0.01% | 4504 |
|
|
2022
Q1 | – | Sell |
-100
| Closed | -$2K | – | 8568 |
|
|
2021
Q4 | $2K | Sell |
100
-200
| -67% | -$5.46K | ﹤0.01% | 7898 |
|
|
2021
Q3 | $9K | Sell |
300
-29,600
| -99% | -$1.08M | ﹤0.01% | 7558 |
|
|
2021
Q2 | $1.32M | Buy |
29,900
+23,100
| +340% | +$1M | ﹤0.01% | 3090 |
|
|
2021
Q1 | $302K | Sell |
6,800
-3,700
| -35% | -$203K | ﹤0.01% | 4569 |
|
|
2020
Q4 | $576K | Sell |
10,500
-16,900
| -62% | -$616K | ﹤0.01% | 3147 |
|
|
2020
Q3 | $626K | Buy |
27,400
+7,400
| +37% | +$182K | ﹤0.01% | 2647 |
|
|
2020
Q2 | $419K | Buy |
+20,000
| New | +$361K | ﹤0.01% | 2782 |
|
|
2020
Q1 | – | Sell |
-4,000
| Closed | -$91K | – | 5659 |
|
|
2019
Q4 | $91K | Buy |
+4,000
| New | +$66.8K | ﹤0.01% | 3695 |
|
|
2018
Q3 | – | Sell |
-900
| Closed | -$18K | – | 5542 |
|
|
2018
Q2 | $18K | Sell |
900
-1,100
| -55% | -$20.8K | ﹤0.01% | 4409 |
|
|
2018
Q1 | $38K | Sell |
2,000
-1,750
| -47% | -$28.5K | ﹤0.01% | 3782 |
|
|
2017
Q4 | $39K | Buy |
3,750
+500
| +15% | +$4.96K | ﹤0.01% | 3853 |
|
|
2017
Q3 | $23K | Buy |
+3,250
| New | +$14.9K | ﹤0.01% | 4006 |
|
|
2017
Q2 | – | Sell |
-6,525
| Closed | -$52K | – | 5020 |
|
|
2017
Q1 | $52K | Sell |
6,525
-3,900
| -37% | -$26.2K | ﹤0.01% | 3378 |
|
|
2016
Q4 | $254K | Buy |
+10,425
| New | +$297K | ﹤0.01% | 2259 |
|
Other funds holding RCKT
RI
VPM
VCM
MC
NM
N
Group One Trading's RCKT Position: Q1 2026 in Review
Group One Trading increased its Rocket Pharmaceuticals (RCKT) stake by 523% in Q1 2026, buying an estimated $191K and bringing the position to 57,382 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #4087.
Group One Trading first reported a position in RCKT in Q3 2016 and has held it in 19 quarters since. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.
- Group One Trading held 57,382 shares of Rocket Pharmaceuticals worth $205K as of Q1 2026.
- Group One Trading bought 48,178 Rocket Pharmaceuticals shares in Q1 2026, an estimated $191K.
- Rocket Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4087 holding.
- Group One Trading first reported a position in Rocket Pharmaceuticals in Q3 2016 and has held it in 19 quarters since.
- 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.